Delivery Order SPE2DB22D3501-SPE2DB25FTN66
Award Date
11/19/24
Potential Completion Date
12/11/24
Potential Value
$9.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,584.58 firm fixed-price delivery order is for the supply of TRODELVY 180MG VIAL 1S medical products, with a completion date of July 3, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRODELVY 180 MG VIALS, with a ceiling value of $6,389.72 and a completion date of July 15, 2025. This is a firm fixed-price delivery order contract, which is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,584.58 firm-fixed-price delivery order is for the supply of TRODELVY 180MG VIAL 1S, a medical product, with a period of performance through June 12, 2025. The contract is not set aside and is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,643.92 Firm Fixed Price Delivery Order covers the supply of TRODELVY 180 MG VIALS, a specialty medication. The contract has an ultimate completion date of January 9, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award, valued at $9,584.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TRODELVY 180 MG VIALS, a specialized pharmaceutical product. The contract has an ultimate completion date of February 7, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor and holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The specific contract award is for the supply of TRODELVY 180 MG VIALS, a specialty medication, at a ceiling value of $15,536.60. The contract has a firm fixed price and an ultimate completion date of January 2, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $6,007.00 firm fixed price delivery order is for the supply of TRODELVY 180 MG VIALS, a specialty pharmaceutical product, with a performance period ending on February 28, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The $6,007.00 firm-fixed price delivery order is for the supply of TRODELVY 180 MG VIALS, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRODELVY 180 MG VIALS. The contract has a firm fixed price of $9,584.58 and a completion date of May 12, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $15,017.50, is for the delivery of 4564338122 - TRODELVY 180 MG VIALS. The contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a total potential value of up to $999,999,999.00 through December 31, 2025. This single-award...